首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1812436

蛋白質治療市場按產品類型、應用、技術、給藥途徑和最終用戶（醫院、診所、研究機構、製藥和生物技術公司）分類

Protein Therapeutics Market, By Product Type, By Application, By Technology, By Route of Administration,By End User: Hospitals, Clinics, Research Laboratories, and Pharmaceutical and Biotechnology Companies

出版日期: 2025年08月21日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

蛋白質治療市場規模預計在 2025 年達到 3,458.2 億美元，預計到 2032 年將達到 5,589.5 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 7.1%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	3458.2億美元
效能數據	2020-2024	預測期	2020-2024
預測期間（2025-2032年）的複合年成長率：	7.10%	2032年預測	5589.5億美元

全球蛋白質療法市場是製藥業一個快速發展的領域，其特點是開發和商業化用於治療各種疾病和病症的治療性蛋白質。蛋白質療法涵蓋各種生物分子，例如單株抗體、重組蛋白、疫苗、血液因子和酵素療法，它們利用人體自身的蛋白質機制進行治療性介入。

在生物技術進步、對蛋白質結構與功能關係理解的加深以及能夠大規模生產複雜生物分子的先進製造流程的推動下，這個市場正在經歷前所未有的成長。治療應用涵蓋多個疾病領域，包括癌症、自體免疫疾病、代謝性疾病、感染疾病和罕見遺傳疾病，使蛋白質療法成為現代醫學中最通用和最有前景的領域之一。

隨著慢性病的增加、全球人口老化以及個人化醫療需求的不斷成長，蛋白質治療市場繼續吸引製藥公司、生物技術公司和研究機構的大量投資，使其成為未來醫療保健解決方案和醫療創新策略的關鍵組成部分。

市場動態

全球蛋白質療法市場受多個關鍵因素驅動，這些因素推動了其強勁的成長軌跡。癌症、糖尿病、自體免疫疾病和心血管疾病等慢性疾病的日益流行，對創新蛋白質治療方案的需求巨大，這些方案與傳統小分子藥物相比，療效更佳，副作用更少。重組DNA技術、蛋白質工程和生物加工能力的進步顯著提高了複雜蛋白質療法的開發和生產效率，同時法律規範也在不斷發展，以支持突破性療法的快速核准途徑。

全球人口老化加劇了對有效治療與老齡化相關疾病的需求，而對個人化醫療的日益深入理解也推動了標靶蛋白質療法的需求。然而，該市場面臨許多限制因素，包括極高的研發成本、需要專業設施和專業知識的複雜製造流程、延長開發週期的嚴格監管要求，以及與蛋白質穩定性、儲存和遞送相關的重大挑戰。

重磅蛋白質藥物的專利到期可能導致來自生物相似藥的競爭，並影響原廠藥製造商的收益來源。儘管存在這些挑戰，但仍存在重大機遇，包括新興市場的擴張、抗體藥物複合體和雙特異性抗體等下一代蛋白質工程技術的開發、其在治療罕見疾病（這些疾病存在大量未滿足的醫療需求）中的應用擴展，以及將聯合治療治療方法改善治療效果和患者護理的聯合療法的日益普及。

本次調查的主要特點

本報告對全球蛋白質治療市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還揭示了各個領域的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、業績和策略等參數，概述了全球蛋白質治療市場的主要企業。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興車型、市場擴張和行銷策略做出明智的決策。
全球蛋白質治療市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球蛋白質治療市場的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 345.82 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.10%	2032 Value Projection:	USD 558.95 Bn

The global protein therapeutics market represents a rapidly evolving segment within the pharmaceutical industry, characterized by the development and commercialization of therapeutic proteins designed to treat various diseases and medical conditions. Protein therapeutics encompass a diverse range of biological molecules including monoclonal antibodies, recombinant proteins, vaccines, blood factors, and enzyme therapies that leverage the body's natural protein mechanisms for therapeutic intervention.

This market has experienced unprecedented growth driven by advancements in biotechnology, improved understanding of protein structure-function relationships, and sophisticated manufacturing processes that enable large-scale production of complex biological molecules. The therapeutic applications span across multiple disease areas including oncology, autoimmune disorders, metabolic diseases, infectious diseases, and rare genetic conditions, making protein therapeutics one of the most versatile and promising segments in modern medicine.

With increasing prevalence of chronic diseases, aging populations worldwide, and growing demand for personalized medicine approaches, the protein therapeutics market continues to attract significant investment from pharmaceutical companies, biotechnology firms, and research institutions, positioning it as a critical component of future healthcare solutions and medical innovation strategies.

Market Dynamics

The global protein therapeutics market is primarily driven by several key factors that collectively propel its robust growth trajectory. The increasing prevalence of chronic diseases such as cancer, diabetes, autoimmune disorders, and cardiovascular conditions creates substantial demand for innovative protein-based therapeutic solutions that offer superior efficacy and reduced side effects compared to traditional small-molecule drugs. Technological advancements in recombinant DNA technology, protein engineering, and bioprocessing capabilities have significantly enhanced the development and manufacturing efficiency of complex protein therapeutics, while regulatory frameworks have evolved to support faster approval pathways for breakthrough therapies.

The growing aging population worldwide amplifies the need for effective treatments for age-related diseases, and the expanding understanding of personalized medicine drives demand for targeted protein therapies. However, the market faces notable restraints including extremely high research and development costs, complex manufacturing processes requiring specialized facilities and expertise, stringent regulatory requirements that extend development timelines, and significant challenges related to protein stability, storage, and delivery.

Patent expiration of blockbuster protein drugs leads to biosimilar competition, potentially impacting revenue streams for original manufacturers. Despite these challenges, substantial opportunities exist through emerging markets expansion, development of next-generation protein engineering technologies such as antibody-drug conjugates and bispecific antibodies, increasing applications in rare disease treatments where unmet medical needs remain high, and growing adoption of combination therapies that integrate protein therapeutics with other treatment modalities to enhance therapeutic outcomes and patient care.

Key Features of the Study

This report provides in-depth analysis of the global protein therapeutics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global protein therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Amgen Inc, Thermo Fisher Scientific Inc, Genentech (Roche), AbbVie Inc, Novo Nordisk, Merck and Co., Johnson and Johnson, Eli Lilly and Company, Pfizer Inc, Regeneron Pharmaceuticals, Biogen Inc, AstraZeneca, Gilead Sciences, Bristol-Myers Squibb, and Aurigene Pharmaceutical Services Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global protein therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global protein therapeutics market

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Monoclonal Antibodies (mAbs)
- Insulin and Analogues
- Recombinant Proteins
- Fusion Proteins
- Blood Factors
- Human Growth Hormones (hGH)
- Follicle-Stimulating Hormone (FSH)
- Interferons
- Others (e.g., Erythropoietin, etc.)
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Cancer Treatment
- Autoimmune Diseases
- Infectious Diseases
- Hemophilia and Coagulation Disorders
- Diabetes
- Cardiovascular Diseases
- Neurological Disorders
- Genetic Disorders
Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Recombinant DNA Technology
- Cell-Based Technology
- Hybridoma Technology
- Others (Gene Editing, Transfection)
Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Parenteral (Injectables)
- Oral
- Others (Topical, Nasal)
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Clinics
- Research Laboratories
- Pharmaceutical and Biotechnology Companies
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Amgen Inc
- Thermo Fisher Scientific Inc
- Genentech (Roche)
- AbbVie Inc
- Novo Nordisk
- Merck and Co.
- Johnson and Johnson
- Eli Lilly and Company
- Pfizer Inc
- Regeneron Pharmaceuticals
- Biogen Inc
- AstraZeneca
- Gilead Sciences
- Bristol-Myers Squibb
- Aurigene Pharmaceutical Services Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Protein Therapeutics Market, By Product Type
- Global Protein Therapeutics Market, By Application
- Global Protein Therapeutics Market, By Technology
- Global Protein Therapeutics Market, By Route of Administration
- Global Protein Therapeutics Market, By End User
- Global Protein Therapeutics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Protein Therapeutics Market, By Product Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Monoclonal Antibodies (mAbs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Insulin and Analogues
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Recombinant Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Fusion Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Blood Factors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Human Growth Hormones (hGH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Follicle-Stimulating Hormone (FSH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Interferons
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (e.g., Erythropoietin, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Protein Therapeutics Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cancer Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hemophilia and Coagulation Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Genetic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Protein Therapeutics Market, By Technology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Recombinant DNA Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cell-Based Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hybridoma Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Gene Editing, Transfection)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Protein Therapeutics Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Parenteral (Injectables)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Topical, Nasal)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Protein Therapeutics Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Protein Therapeutics Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
South Africa
North Africa
Central Africa

10. Competitive landscape

Amgen Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Genentech (Roche)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novo Nordisk
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck and Co.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson and Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Regeneron Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biogen Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Gilead Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol-Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Aurigene Pharmaceutical Services Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies